Overview
Status
Active
Registry date
2018-02-19
Share capital
5,000.00 PLN
Registered address
ul. Gen. Władysława Sikorskiego 166/0.03, 18-400 Łomża, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 333 days late).
- 202503/07/2026
- 202425/06/2025
- 202313/07/2024
- 202211/07/2023
- 202113/06/2023
- 202009/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 10.30kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 952.14MedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 9.25kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 45.40kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Marek Adam Olszewski – Vice President
Artur Wilk – President
Manner of representation
In the case of a one-person management board – the member of the management board; in the case of a management board consisting of two or more persons – joint action by two members of the management board or by one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marek Adam Olszewskiage 53 | 50 | $675.31 | 50% |
Artur Wilkage 40 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A. | $146,864,520.79 | multipharme.pl | ||
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | ||
| Cirrosp. z o.o. | $20,863,166.14 | cirro.pl | ||
| Premmier Redsp. z o.o. | $2,723,178.99 | premmier.com | ||
| Aptekssp. z o.o. | $13,537.42 | apteks.com | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Polidental Tradesp. z o.o. | $9,409.06 | poli.dental | ||
| Endolink PharmaS.A. | $7,191.18 | endolink.pl | ||
| Temedasp. z o.o. | – | temeda.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-10-02 | Address change (Ul. Gen. Władysława Sikorskiego 166, 18-400, Łomża → Ul. Gen. Władysława Sikorskiego 166/0.03, 18-400, Łomża) | |
| 2018-02-19 | Entered in the register |
FAQ
The main business activity of Validus focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 19, 2018.
The headquarters is located at: ul. Gen. Władysława Sikorskiego 166, 18-400 Łomża.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $84,290, representing an increase of 24.7% compared to 2023.
Yes, in 2024 the company was profitable, achieving a net profit of $191, meaning the company decreased its profit by 91.9%.
The largest operating cost category falls under materials and energy. This category amounted to $75,219 in 2024, representing 89% of all operating expenses.
Last updated: 2026-07-03
